179 related articles for article (PubMed ID: 31255259)
1. Rate of BRCA mutation in patients tested under NCCN genetic testing criteria.
Beck AC; Yuan H; Liao J; Imperiale P; Shipley K; Erdahl LM; Sugg SL; Weigel RJ; Lizarraga IM
Am J Surg; 2020 Jan; 219(1):145-149. PubMed ID: 31255259
[TBL] [Abstract][Full Text] [Related]
2. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
3. Preoperative genetic testing affects surgical decision making in breast cancer patients.
Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
[TBL] [Abstract][Full Text] [Related]
4. Selected medical interventions in women with a deleterious
Hanley GE; McAlpine JN; Cheifetz R; Schrader KA; McCullum M; Huntsman D
Curr Oncol; 2019 Feb; 26(1):e17-e23. PubMed ID: 30853805
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Kemp Z; Turnbull A; Yost S; Seal S; Mahamdallie S; Poyastro-Pearson E; Warren-Perry M; Eccleston A; Tan MM; Teo SH; Turner N; Strydom A; George A; Rahman N
JAMA Netw Open; 2019 May; 2(5):e194428. PubMed ID: 31125106
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the NCCN Clinical Criteria for Recommending
Cropper C; Woodson A; Arun B; Barcenas C; Litton J; Noblin S; Liu D; Park M; Daniels M
J Natl Compr Canc Netw; 2017 Jun; 15(6):797-803. PubMed ID: 28596260
[No Abstract] [Full Text] [Related]
7. Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.
Hartman AR; Kaldate RR; Sailer LM; Painter L; Grier CE; Endsley RR; Griffin M; Hamilton SA; Frye CA; Silberman MA; Wenstrup RJ; Sandbach JF
Cancer; 2012 Jun; 118(11):2787-95. PubMed ID: 22614657
[TBL] [Abstract][Full Text] [Related]
8. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
9. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
[TBL] [Abstract][Full Text] [Related]
10. Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Eccles DM; Balmaña J; Clune J; Ehlken B; Gohlke A; Hirst C; Potter D; Schroeder C; Tyczynski JE; Gomez Garcia EB
Adv Ther; 2016 Feb; 33(2):129-50. PubMed ID: 26809252
[TBL] [Abstract][Full Text] [Related]
11. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
[TBL] [Abstract][Full Text] [Related]
12. BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.
Chun DS; Berse B; Venne VL; DuVall SL; Filipski KK; Kelley MJ; Meyer LJ; Icardi MS; Lynch JA
Fam Cancer; 2017 Jan; 16(1):41-49. PubMed ID: 27589855
[TBL] [Abstract][Full Text] [Related]
13. Risk management options elected by women after testing positive for a BRCA mutation.
Garcia C; Wendt J; Lyon L; Jones J; Littell RD; Armstrong MA; Raine-Bennett T; Powell CB
Gynecol Oncol; 2014 Feb; 132(2):428-33. PubMed ID: 24355485
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
[TBL] [Abstract][Full Text] [Related]
15. Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients.
Vig HS; McCarthy AM; Liao K; Demeter MB; Fredericks T; Armstrong K
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1778-85. PubMed ID: 23917453
[TBL] [Abstract][Full Text] [Related]
16. Missed opportunities in the real-world genetic testing in BRCA gene variant carriers with cancers meeting NCCN criteria.
Lee SS; Rajeev P; Finning S; Oh C; Pothuri B
Gynecol Oncol; 2023 Mar; 170():32-37. PubMed ID: 36610379
[TBL] [Abstract][Full Text] [Related]
17. Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing.
Lattimore V; Currie M; Lintott C; Sullivan J; Robinson BA; Walker LC
N Z Med J; 2015 Aug; 128(1419):56-61. PubMed ID: 26365847
[TBL] [Abstract][Full Text] [Related]
18. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
19. Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.
Nilsson MP; Winter C; Kristoffersson U; Rehn M; Larsson C; Saal LH; Loman N
Fam Cancer; 2017 Apr; 16(2):187-193. PubMed ID: 28120249
[TBL] [Abstract][Full Text] [Related]
20. Use of BRCA Mutation Test in the U.S., 2004-2014.
Guo F; Hirth JM; Lin YL; Richardson G; Levine L; Berenson AB; Kuo YF
Am J Prev Med; 2017 Jun; 52(6):702-709. PubMed ID: 28342662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
